Explaining why childhood abuse is a risk factor for poorer clinical course in bipolar disorder: a path analysis of 923 people with bipolar I disorder.
Affective instability
bipolar disorder
childhood abuse
impulsivity
path analysis
Journal
Psychological medicine
ISSN: 1469-8978
Titre abrégé: Psychol Med
Pays: England
ID NLM: 1254142
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
pubmed:
19
9
2019
medline:
20
8
2021
entrez:
19
9
2019
Statut:
ppublish
Résumé
Childhood abuse is a risk factor for poorer illness course in bipolar disorder, but the reasons why are unclear. Trait-like features such as affective instability and impulsivity could be part of the explanation. We aimed to examine whether childhood abuse was associated with clinical features of bipolar disorder, and whether associations were mediated by affective instability or impulsivity. We analysed data from 923 people with bipolar I disorder recruited by the Bipolar Disorder Research Network. Adjusted associations between childhood abuse, affective instability and impulsivity and eight clinical variables were analysed. A path analysis examined the direct and indirect links between childhood abuse and clinical features with affective instability and impulsivity as mediators. Affective instability significantly mediated the association between childhood abuse and earlier age of onset [effect estimate (θ)/standard error (SE): 2.49], number of depressive (θ/SE: 2.08) and manic episodes/illness year (θ/SE: 1.32), anxiety disorders (θ/SE: 1.98) and rapid cycling (θ/SE: 2.25). Impulsivity significantly mediated the association between childhood abuse and manic episodes/illness year (θ/SE: 1.79), anxiety disorders (θ/SE: 1.59), rapid cycling (θ/SE: 1.809), suicidal behaviour (θ/SE: 2.12) and substance misuse (θ/SE: 3.09). Measures of path analysis fit indicated an excellent fit to the data. Affective instability and impulsivity are likely part of the mechanism of why childhood abuse increases risk of poorer clinical course in bipolar disorder, with each showing some selectivity in pathways. They are potential novel targets for intervention to improve outcome in bipolar disorder.
Sections du résumé
BACKGROUND
Childhood abuse is a risk factor for poorer illness course in bipolar disorder, but the reasons why are unclear. Trait-like features such as affective instability and impulsivity could be part of the explanation. We aimed to examine whether childhood abuse was associated with clinical features of bipolar disorder, and whether associations were mediated by affective instability or impulsivity.
METHODS
We analysed data from 923 people with bipolar I disorder recruited by the Bipolar Disorder Research Network. Adjusted associations between childhood abuse, affective instability and impulsivity and eight clinical variables were analysed. A path analysis examined the direct and indirect links between childhood abuse and clinical features with affective instability and impulsivity as mediators.
RESULTS
Affective instability significantly mediated the association between childhood abuse and earlier age of onset [effect estimate (θ)/standard error (SE): 2.49], number of depressive (θ/SE: 2.08) and manic episodes/illness year (θ/SE: 1.32), anxiety disorders (θ/SE: 1.98) and rapid cycling (θ/SE: 2.25). Impulsivity significantly mediated the association between childhood abuse and manic episodes/illness year (θ/SE: 1.79), anxiety disorders (θ/SE: 1.59), rapid cycling (θ/SE: 1.809), suicidal behaviour (θ/SE: 2.12) and substance misuse (θ/SE: 3.09). Measures of path analysis fit indicated an excellent fit to the data.
CONCLUSIONS
Affective instability and impulsivity are likely part of the mechanism of why childhood abuse increases risk of poorer clinical course in bipolar disorder, with each showing some selectivity in pathways. They are potential novel targets for intervention to improve outcome in bipolar disorder.
Identifiants
pubmed: 31530330
doi: 10.1017/S0033291719002411
pii: S0033291719002411
pmc: PMC7610181
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2346-2354Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L010305/1
Pays : United Kingdom
Références
Eur Psychiatry. 2015 Jan;30(1):106-13
pubmed: 25280430
J Psychiatr Res. 2017 Dec;95:37-45
pubmed: 28777981
Int J Bipolar Disord. 2014 Dec;2(1):11
pubmed: 26092397
Eur Neuropsychopharmacol. 2018 Jul;28(7):807-817
pubmed: 29866576
J Affect Disord. 2018 Dec 1;241:492-498
pubmed: 30149337
J Psychiatr Res. 2017 Jan;84:73-79
pubmed: 27705819
Arch Gen Psychiatry. 1990 Jun;47(6):589-93
pubmed: 2190539
Br J Psychiatry. 2016 Apr;208(4):352-8
pubmed: 26795426
Neurosci Lett. 2010 Jan 18;469(1):75-80
pubmed: 19932153
Psychol Med. 2014 Jul;44(9):1793-808
pubmed: 24074230
Soc Psychiatry Psychiatr Epidemiol. 2013 Sep;48(9):1431-7
pubmed: 23344782
Borderline Personal Disord Emot Dysregul. 2016 Dec 13;3:17
pubmed: 27999677
J Affect Disord. 2016 Aug;200:159-64
pubmed: 27136413
Bipolar Disord. 2008 Dec;10(8):867-76
pubmed: 19594502
World J Biol Psychiatry. 2019 Feb;20(2):137-149
pubmed: 28914102
Front Psychiatry. 2016 Oct 26;7:174
pubmed: 27833568
Am J Psychiatry. 2005 Sep;162(9):1680-7
pubmed: 16135628
Bipolar Disord. 2017 Aug;19(5):353-362
pubmed: 28699182
Neuropsychopharmacology. 2001 May;24(5):467-77
pubmed: 11282247
Aust N Z J Psychiatry. 2015 Jun;49(6):557-65
pubmed: 25850428
J Affect Disord. 2017 Oct 1;220:147-155
pubmed: 28623759
Acta Psychiatr Scand. 2014 Feb;129(2):100-8
pubmed: 23600731
J Affect Disord. 2016 Jan 15;190:764-771
pubmed: 26615365
Lancet Psychiatry. 2015 Jul;2(7):618-24
pubmed: 26303559
J Psychiatr Res. 2001 Nov-Dec;35(6):307-12
pubmed: 11684137
Trends Neurosci. 2018 Jan;41(1):18-30
pubmed: 29169634
J Affect Disord. 2009 Jan;112(1-3):144-50
pubmed: 18538857
J Affect Disord. 2016 Jul 1;198:88-95
pubmed: 27011364
Aust N Z J Psychiatry. 2014 Jun;48(6):564-70
pubmed: 24343193
Bipolar Disord. 2012 Aug;14(5):565-70
pubmed: 22805501
Neurosci Biobehav Rev. 2015 Apr;51:243-54
pubmed: 25662294
Acta Psychiatr Scand. 2011 Dec;124(6):427-34
pubmed: 21848703
Ther Adv Psychopharmacol. 2018 Apr 26;8(9):251-269
pubmed: 30181867
J Affect Disord. 2015 Feb 1;172:375-80
pubmed: 25451440
Am J Psychiatry. 2001 Nov;158(11):1871-7
pubmed: 11691694
Lancet Psychiatry. 2016 Apr;3(4):342-9
pubmed: 26873185
J Affect Disord. 2014 Oct;168:58-63
pubmed: 25036010
Lancet. 1997 May 17;349(9063):1436-42
pubmed: 9164317
Psychol Med. 2011 Aug;41(8):1567-77
pubmed: 20836910
Bipolar Disord. 2018 Feb;20(1):18-26
pubmed: 28833984
Bipolar Disord. 2009 May;11(3):280-8
pubmed: 19419385
Schizophr Bull. 2018 Oct 17;44(6):1267-1274
pubmed: 29207008
Bipolar Disord. 2012 Feb;14(1):80-9
pubmed: 22329475
Psychol Med. 2017 Apr;47(5):902-912
pubmed: 27894372
Acta Psychiatr Scand. 2013 Sep;128(3):194-202
pubmed: 23331090
Neuropsychopharmacology. 2014 Jul;39(8):1914-23
pubmed: 24535101
J Clin Psychol. 1995 Nov;51(6):768-74
pubmed: 8778124
Psychiatry Res. 2008 May 30;159(1-2):1-6
pubmed: 18295902
Psychol Med. 1985 Feb;15(1):189-94
pubmed: 3991833
World Psychiatry. 2017 Oct;16(3):236-244
pubmed: 28941093
Am J Psychiatry. 2001 Nov;158(11):1783-93
pubmed: 11691682
Br J Psychiatry. 2015 Oct;207(4):283-5
pubmed: 26429679
Eur Neuropsychopharmacol. 2007 Apr;17(5):313-20
pubmed: 17140772
Lancet. 2011 Jun 18;377(9783):2093-102
pubmed: 21652063
Biol Psychiatry. 1997 Nov 15;42(10):948-55
pubmed: 9359982
Br J Psychiatry. 2015 Mar;206(3):191-7
pubmed: 25614532
J Clin Psychiatry. 2013 Oct;74(10):991-8
pubmed: 24229750